Treats Parkinson's disease. ANDA 202702, held by Strides Pharma. Pramipexole Dihydrochloride.
As of Nov 21, 2026, ANDA 202702 (Pramipexole Dihydrochloride), held by Strides Pharma, was first approved by FDA on Jun 3, 2014, with 4 approved supplements and 0 published complete response letters.
Pramipexole dihydrochloride tablets is a non-ergot dopamine agonist indicated for the treatment of: Parkinson's disease (PD) Moderate-to-severe primary Restless Legs Syndrome (RLS) 1.1 Parkinson’s Disease Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson's disease. 1.2 Restless Legs Syndrome Pramipexole dihydrochloride tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 3, 2014 | Original application | Approved | None posted |
| Pramipexole Dihydrochloride0.125MG · tablet;oral | Pramipexole Dihydrochloride | Rx |
| Pramipexole Dihydrochloride0.25MG · tablet;oral | Pramipexole Dihydrochloride | Rx |
| Pramipexole Dihydrochloride0.5MG · tablet;oral | Pramipexole Dihydrochloride | Rx |
| Pramipexole Dihydrochloride0.75MG · tablet;oral | Pramipexole Dihydrochloride | Rx |
| Pramipexole Dihydrochloride1MG · tablet;oral | Pramipexole Dihydrochloride | Rx |
| Pramipexole Dihydrochloride1.5MG · tablet;oral | Pramipexole Dihydrochloride | Rx |
| Feb 7, 2024 | Supplement 1Labeling · Standard review | Approved | None posted |
| Feb 7, 2024 | Supplement 2Labeling · Standard review | Approved | None posted |
| Feb 7, 2024 | Supplement 3Labeling · Standard review | Approved | None posted |
| Feb 7, 2024 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jun 3, 2014 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters